Summit Therapeutics Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Buy

SMMT
Summit Therapeutics

Last Price:

$25.84

Seasonality Move:

6.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Summit Therapeutics Stock Forecast

Over the next 52 weeks, Summit Therapeutics has on average historically risen by 80% based on the past 10 years of stock performance.
Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Summit Therapeutics Stock Undervalued?

The current Summit Therapeutics [SMMT] share price is $25.85. The Score for SMMT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Summit Therapeutics has on average historically risen by 80% based on the past 10 years of stock performance.

Summit Therapeutics Stock Rating

Buy

Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics overpriced?

Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

smmttx.com

52-Week Data

52-Week High:

36.91

52-Week Low:

2.10

Prediction Charts

Market Cap:

19.2B

Price in USD:

25.85

Volume:

1.8M

Beta:

-0.18

Technical Analysis

SMA50:

23.02

SMA100:

21.50

SMA200:

19.89

52-Wk Change:

498.38%

Stock Predictions

Is Summit Therapeutics stock public?

Yes, Summit Therapeutics is a publicly traded company.
What is the Summit Therapeutics stock quote today?

The Summit Therapeutics stock price is 25.85 USD today.
How to buy Summit Therapeutics stock online?

You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-6	26.95	24.20	27.09	23.81
May-7	24.54	24.29	24.73	23.80
May-8	24.48	24.65	25.79	23.96
May-9	24.65	23.96	25.34	23.45
May-12	23.26	25.26	25.30	23.26
May-13	25.39	24.61	25.50	24.21
May-14	24.50	22.75	25.07	22.51
May-15	22.50	23.09	23.34	21.75
May-16	23.14	23.87	23.94	23.04
May-19	23.80	24.01	24.02	22.85
May-20	23.64	24.39	24.45	23.45
May-21	24.13	25.41	26.85	23.88
May-22	25.62	25.77	26.44	25.05
May-23	25.48	25.85	26.17	25.12

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.